Alligator, founded in 2001, develops biological drugs for the treatment of cancer. The company uses a technique to activate the patient's own defense to cure cancer. The company focuses on indicating tumor-rich drugs, where the drug is designed in such a way that its immune activating effect is localized to the tumor. This results in an advantageous efficacy and safety profile. Alligator is primarily active in the early phases of drug development, from idea to clinical Phase II studies.